BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/DCLK1/Compounds

Compounds That Target DCLK1

doublecortin like kinase 1 · 16 compounds in BiohacksAI corpus

DCLK1 (doublecortin like kinase 1) is a biological target with 16 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into DCLK1 modulation for therapeutic and biohacking applications.

View DCLK1 target page →UniProt: O15075 ↗
Most Studied Compounds for DCLK1
1
Crizotinib
298+
studies
All 16 Compounds — Ranked by Evidence
1
Tofacitinib
4.65
confidence
2
Alvocidib
4.52
confidence
3
Ruxolitinib
4.23
confidence
4
Bi 2536
4.01
confidence
5
Nintedanib
3.61
confidence
6
Bms 387032
3.47
confidence
7
Tae 684
3.43
confidence
8
Fedratinib
3.40
confidence
9
Jnj 7706621
3.09
confidence
10
Pha 665752
2.71
confidence
11
Plx 4720
2.71
confidence
12
Kw 2449
2.64
confidence
13
Gsk 690693
2.64
confidence
14
Bms 754807
2.30
confidence
15
Su 014813
2.20
confidence
16
Crizotinib
298+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for DCLK1 (doublecortin like kinase 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: DCLK1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.